Effectiveness of Nirmatrelvir-Ritonavir for the treatment of patients with mild to moderate COVID-19 and at high risk of hospitalization: Systematic review and meta-analyses of observational studies
View ORCID ProfileKathiaja Miranda Souza, Gabriela Carrasco, Robin Rojas-Cortés, Mariana Michel Barbosa, View ORCID ProfileEduardo Henrique Ferreira Bambirra, José Luis Castro, Juliana Alvares-Teodoro
doi: https://doi.org/10.1101/2023.03.27.23287621
Kathiaja Miranda Souza
1Independent Consultant, Belo Horizonte, Brazil
Gabriela Carrasco
2Red Argentina Pública de Evaluación de Tecnologías Sanitarias (REDARETS), Neuquén, Argentina
Robin Rojas-Cortés
3Pan American Health Organization, Department of Health Systems and Services, Unit of Medicines and Health Technologies, Washington DC, United States of America
Mariana Michel Barbosa
4Postgraduate Program in Medicines and Pharmaceutical Services, Federal University of Minas Gerais, Belo Horizonte, Minas Gerais, Brazil
Eduardo Henrique Ferreira Bambirra
4Postgraduate Program in Medicines and Pharmaceutical Services, Federal University of Minas Gerais, Belo Horizonte, Minas Gerais, Brazil
José Luis Castro
5Fundación para la innovación, la formación, la investigación y el desarrollo comunitário (FUNDEC). San Isidro, S/C de Tenerife. España
Juliana Alvares-Teodoro
4Postgraduate Program in Medicines and Pharmaceutical Services, Federal University of Minas Gerais, Belo Horizonte, Minas Gerais, Brazil
6Department of Social Pharmacy, Faculty of Pharmacy, Federal University of Minas Gerais, Belo Horizonte, Minas Gerais, Brazil
Posted March 29, 2023.
Effectiveness of Nirmatrelvir-Ritonavir for the treatment of patients with mild to moderate COVID-19 and at high risk of hospitalization: Systematic review and meta-analyses of observational studies
Kathiaja Miranda Souza, Gabriela Carrasco, Robin Rojas-Cortés, Mariana Michel Barbosa, Eduardo Henrique Ferreira Bambirra, José Luis Castro, Juliana Alvares-Teodoro
medRxiv 2023.03.27.23287621; doi: https://doi.org/10.1101/2023.03.27.23287621
Effectiveness of Nirmatrelvir-Ritonavir for the treatment of patients with mild to moderate COVID-19 and at high risk of hospitalization: Systematic review and meta-analyses of observational studies
Kathiaja Miranda Souza, Gabriela Carrasco, Robin Rojas-Cortés, Mariana Michel Barbosa, Eduardo Henrique Ferreira Bambirra, José Luis Castro, Juliana Alvares-Teodoro
medRxiv 2023.03.27.23287621; doi: https://doi.org/10.1101/2023.03.27.23287621
Subject Area
Subject Areas
- Addiction Medicine (359)
- Allergy and Immunology (681)
- Anesthesia (182)
- Cardiovascular Medicine (2702)
- Dermatology (231)
- Emergency Medicine (408)
- Epidemiology (12343)
- Forensic Medicine (10)
- Gastroenterology (774)
- Genetic and Genomic Medicine (4188)
- Geriatric Medicine (394)
- Health Economics (690)
- Health Informatics (2708)
- Health Policy (1012)
- Hematology (366)
- HIV/AIDS (869)
- Medical Education (401)
- Medical Ethics (110)
- Nephrology (447)
- Neurology (3974)
- Nursing (216)
- Nutrition (587)
- Oncology (2093)
- Ophthalmology (597)
- Orthopedics (245)
- Otolaryngology (309)
- Pain Medicine (254)
- Palliative Medicine (76)
- Pathology (474)
- Pediatrics (1137)
- Primary Care Research (464)
- Public and Global Health (6603)
- Radiology and Imaging (1432)
- Respiratory Medicine (879)
- Rheumatology (416)
- Sports Medicine (347)
- Surgery (458)
- Toxicology (56)
- Transplantation (192)
- Urology (170)